Innovus Pharmaceuticals Well Capitalized with the Closing of $1.5M in Financing from Institutional Investors
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCQB:INNV), a company focusing on the commercialization of over-the-counter ("OTC") and consumer products for men's and women's health, vitality and respiratory diseases, announced today, the closing of $1.5 million convertible promissory note investment from institutional investors. The convertible promissory notes have a $0.25 fixed conversion price and bear an interest rate of 10% and mature in 13 months.
View full press release